In 2015, Professors Xin Lu and Mark Middleton identified oesophageal cancer as a strategic development opportunity for Oxford. Established in 2024 under the umbrella of Oxford Cancer, the Oesophagogastric Cancer Centre of Excellence aims to build on this work by bringing together a community of clinicians, interdisciplinary scientists and patients dedicated to driving progress and understanding.
By leveraging Oxford’s world-leading scientific insights, an extensive global network of academic and commercial partners, and by working closely with Oxford’s patient advocacy team, the Centre is actively working on key programmes to benefit Oesophagogastric Cancer patients. These programmes aim to develop novel diagnostics, innovative treatments to improve patient outcomes and, ultimately, discover potential cures.
The symposium presented a platform for knowledge exchange and collaboration among leading experts across Oxford and the surrounding area. Participants explored recent advancements in research and clinical practice that are contributing to improved patient care, with the day comprised of a series of presentations and discussions covering topics such as clinical trials, cancer biology, and emerging therapies.
"Improving patient outcomes requires a comprehensive approach," said Professor Mark Middleton, opening the symposium. "It starts with an academic understanding of how oesophageal cancer originates, progresses, and how we can intervene. However, success depends on close collaboration—not only with researchers and clinicians across disciplines but also with patients, whose insights and perspectives are invaluable. By working together nationally and internationally, on fundamental cancer biology, the clinical application of treatments such as radiotherapy, and beyond, we can drive meaningful advancements in treatment and care."
For more information about the Oxford Oesophagogastric Cancer Centre of Excellence, visit our website or email Senior Project Manager, Elizabeth Mann.
